Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002023260-24-000001
Filing Date
2024-05-15
Accepted
2024-05-15 14:07:30
Documents
1
Effectiveness Date
2024-05-15
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6080
  Complete submission text file 0002023260-24-000001.txt   7295
Mailing Address 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE 19703
Business Address 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE 19703 (360) 946-0604
Amytrx Therapeutics Inc. Jan 2024 a Series of CGF2021 LLC (Filer) CIK: 0002023260 (see all company filings)

EIN.: 990904949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-513381 | Film No.: 24949289